IL17A and Miyoshi myopathy: A higher number of Th17 cells has been detected in peripheral blood (PB) and BM from MM patients, and although secreted IL-17 fosters tumor growth [187], an increased population of Th17 cells has been also described in Long-Term Survival (LTS)-MM patients [188].